Palliative Care Services within a Pediatric Hematology-Oncology Program in a Low-Resource Setting.


Journal

Journal of pain and symptom management
ISSN: 1873-6513
Titre abrégé: J Pain Symptom Manage
Pays: United States
ID NLM: 8605836

Informations de publication

Date de publication:
05 2022
Historique:
received: 09 07 2021
revised: 03 01 2022
accepted: 06 01 2022
pubmed: 16 1 2022
medline: 19 4 2022
entrez: 15 1 2022
Statut: ppublish

Résumé

Outcomes for children with cancer in sub-Saharan Africa (SAA) are dismal due to delayed diagnosis and limited access to curative therapy. When establishing a pediatric hematology-oncology (PHO) program in low-resource settings, early integration of palliative care services becomes essential. While palliative care is a human right, equitable distribution is lacking. We aim to describe our experience establishing a palliative care program, the services offered, and the distribution of patients served. This is a brief description of our PHO palliative care program in Lilongwe, Malawi at a tertiary care center and a three-year retrospective review of activities (2017-2020). Services offered include inpatient, outpatient, home visits, end of life care, and strengthening of referral systems. Over the three-year period, 315 patients were enrolled. 57% (n=179) were male. The median age was seven years (5 months-22 years). Patients served were from 17 of 28 districts within Malawi. Diagnoses of patients included 43% solid tumors (n=135), 22% lymphoma (n=68), 15% leukemia (n=47), and 21% hematologic disease (n=65). 40% of patients have died (n=125), with 53% of deaths occurring at home (n=66), 22% in the hospital (n=28), and 25% at unknown locations (n=31). Palliative care is a critical component of PHO programs worldwide. Programs must leverage existing networks to ensure optimal care to children and families. We demonstrate the feasibility of integrating palliative care services within a PHO program in a low-resource setting, which could serve as a model for other countries in SSA.

Identifiants

pubmed: 35031502
pii: S0885-3924(22)00006-9
doi: 10.1016/j.jpainsymman.2022.01.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e473-e480

Informations de copyright

Copyright © 2022 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Allison Silverstein (A)

Global HOPE (Hematology-Oncology-Pediatric-Excellence) Program (A.S., S.T., J.H., J.C., N.O., M.H.H.), Texas Children's Hospital, Houston, Texas, USA; Department of Pediatrics (A.S., S.T., J.H., J.C., N.O., M.H.H.), Baylor College of Medicine, Houston, Texas USA. Electronic address: allison@allisonsilverstein.com.

Mercy Butia (M)

Global HOPE (Hematology-Oncology-Pediatric-Excellence) Program (M.B., R.B., G.M., C.N., N.M., S.M., N.O., M.H.H.), Baylor College of Medicine Children's Foundation, Lilongwe, Malawi.

Rhahim Bank (R)

Global HOPE (Hematology-Oncology-Pediatric-Excellence) Program (M.B., R.B., G.M., C.N., N.M., S.M., N.O., M.H.H.), Baylor College of Medicine Children's Foundation, Lilongwe, Malawi.

Geoffrey Manda (G)

Global HOPE (Hematology-Oncology-Pediatric-Excellence) Program (M.B., R.B., G.M., C.N., N.M., S.M., N.O., M.H.H.), Baylor College of Medicine Children's Foundation, Lilongwe, Malawi.

Constance Nyasulu (C)

Global HOPE (Hematology-Oncology-Pediatric-Excellence) Program (M.B., R.B., G.M., C.N., N.M., S.M., N.O., M.H.H.), Baylor College of Medicine Children's Foundation, Lilongwe, Malawi.

Noel Mwango (N)

Global HOPE (Hematology-Oncology-Pediatric-Excellence) Program (M.B., R.B., G.M., C.N., N.M., S.M., N.O., M.H.H.), Baylor College of Medicine Children's Foundation, Lilongwe, Malawi.

Samuel Makuti (S)

Global HOPE (Hematology-Oncology-Pediatric-Excellence) Program (M.B., R.B., G.M., C.N., N.M., S.M., N.O., M.H.H.), Baylor College of Medicine Children's Foundation, Lilongwe, Malawi.

Maria Chikasema (M)

University of North Carolina Project-Malawi (M.C.), Lilongwe, Malawi.

Susan Torrey (S)

Global HOPE (Hematology-Oncology-Pediatric-Excellence) Program (A.S., S.T., J.H., J.C., N.O., M.H.H.), Texas Children's Hospital, Houston, Texas, USA; Department of Pediatrics (A.S., S.T., J.H., J.C., N.O., M.H.H.), Baylor College of Medicine, Houston, Texas USA.

Joy Hesselgrave (J)

Global HOPE (Hematology-Oncology-Pediatric-Excellence) Program (A.S., S.T., J.H., J.C., N.O., M.H.H.), Texas Children's Hospital, Houston, Texas, USA; Department of Pediatrics (A.S., S.T., J.H., J.C., N.O., M.H.H.), Baylor College of Medicine, Houston, Texas USA.

Jessica Casas (J)

Global HOPE (Hematology-Oncology-Pediatric-Excellence) Program (A.S., S.T., J.H., J.C., N.O., M.H.H.), Texas Children's Hospital, Houston, Texas, USA; Department of Pediatrics (A.S., S.T., J.H., J.C., N.O., M.H.H.), Baylor College of Medicine, Houston, Texas USA.

Lameck Thambo (L)

Palliative Care Association of Malawi (L.T.), Lilongwe, Malawi.

Amos Msekandiana (A)

Department of Pediatrics (A.M., M.C.), Kamuzu Central Hospital, Lilongwe, Malawi.

Msandeni Chiume (M)

Department of Pediatrics (A.M., M.C.), Kamuzu Central Hospital, Lilongwe, Malawi.

Nmazuo Ozuah (N)

Global HOPE (Hematology-Oncology-Pediatric-Excellence) Program (A.S., S.T., J.H., J.C., N.O., M.H.H.), Texas Children's Hospital, Houston, Texas, USA; Department of Pediatrics (A.S., S.T., J.H., J.C., N.O., M.H.H.), Baylor College of Medicine, Houston, Texas USA; Global HOPE (Hematology-Oncology-Pediatric-Excellence) Program (M.B., R.B., G.M., C.N., N.M., S.M., N.O., M.H.H.), Baylor College of Medicine Children's Foundation, Lilongwe, Malawi.

Minke Hw Huibers (MH)

Global HOPE (Hematology-Oncology-Pediatric-Excellence) Program (A.S., S.T., J.H., J.C., N.O., M.H.H.), Texas Children's Hospital, Houston, Texas, USA; Department of Pediatrics (A.S., S.T., J.H., J.C., N.O., M.H.H.), Baylor College of Medicine, Houston, Texas USA; Global HOPE (Hematology-Oncology-Pediatric-Excellence) Program (M.B., R.B., G.M., C.N., N.M., S.M., N.O., M.H.H.), Baylor College of Medicine Children's Foundation, Lilongwe, Malawi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH